Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study

SIMPLE SUMMARY: Herein, we retrospectively analyze in our single-center study real-life data of 357 myeloma and lymphoma patients mobilized with granulocyte colony-stimulating factor plus a fixed dose of Plerixafor when indicated or G-CSF alone. There were no significant differences in engraftment k...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiner, Normann, Göbel, Georg, Mauser, Leonie, Mühlnikel, Lena, Fischinger, Marie, Künz, Tina, Willenbacher, Wolfgang, Hetzenauer, Gabriele, Rudzki, Jakob, Nussbaumer, Walter, Mayer, Wolfgang, Gunsilius, Eberhard, Kircher, Brigitte, Wolf, Dominik, Nachbaur, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913576/
https://www.ncbi.nlm.nih.gov/pubmed/36765566
http://dx.doi.org/10.3390/cancers15030608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913576/
https://www.ncbi.nlm.nih.gov/pubmed/36765566
http://dx.doi.org/10.3390/cancers15030608

Ejemplares similares